61830-09-9 Usage
Uses
Used in Synthetic Organic Chemistry:
3,5-DIBROMO-PYRIDINE-2-CARBONITRILE is used as a key intermediate in the synthesis of various organic compounds for research and development purposes. Its unique structure, featuring bromine and nitrogen-containing groups, allows it to react with other chemical substances, making it a valuable component in the creation of new organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3,5-DIBROMO-PYRIDINE-2-CARBONITRILE is used as a building block for the development of new drugs. Its reactivity and structural properties enable the synthesis of novel compounds with potential therapeutic applications, contributing to the discovery of new medications for various diseases and conditions.
Used in Agrochemical Industry:
3,5-DIBROMO-PYRIDINE-2-CARBONITRILE is also utilized in the agrochemical industry as a precursor for the synthesis of pesticides and other crop protection agents. Its ability to react with other chemicals allows for the development of innovative and effective products to protect crops from pests and diseases, ensuring food security and agricultural productivity.
Used in Dye and Pigment Industry:
In the dye and pigment industry, 3,5-DIBROMO-PYRIDINE-2-CARBONITRILE is employed as a starting material for the production of various dyes and pigments. Its unique chemical properties enable the creation of new colorants with improved performance characteristics, such as enhanced color strength, stability, and resistance to fading.
Used in Research and Development:
3,5-DIBROMO-PYRIDINE-2-CARBONITRILE is extensively used in research and development settings to explore its potential applications and properties. Scientists and researchers utilize 3,5-DIBROMO-PYRIDINE-2-CARBONITRILE to investigate its reactivity, stability, and interactions with other chemicals, leading to a deeper understanding of its behavior and potential uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 61830-09-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,3 and 0 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 61830-09:
(7*6)+(6*1)+(5*8)+(4*3)+(3*0)+(2*0)+(1*9)=109
109 % 10 = 9
So 61830-09-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H2Br2N2/c7-4-1-5(8)6(2-9)10-3-4/h1,3H
61830-09-9Relevant academic research and scientific papers
HIV INTEGRASE INHIBITORS
-
, (2015/09/22)
The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
PICOLINAMIDE INHIBITORS OF KINASES
-
Page/Page column 20, (2012/07/31)
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, A, B, Z, n, and m are defined in the description. The present invention relates also to compositions contain
HIV INTEGRASE INHIBITORS
-
Page/Page column 56-57, (2008/06/13)
The present infention features compounds that are HIV integrase inhibitors and may be useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
Cyclic compounds
-
, (2008/06/13)
1. A cyclic compound of the formula (I) or a pharmacologically acceptable salt thereof, wherein X is ═CH— or ═N—, Y is —NH—, —NR4—, —S—, —O—, —CH═N—, —N═CH—, —N═N—, —CH═CH—, etc., R1 is a lower alkoxy group, an amino group, a heterocyclic ring containing N atom(s), or a hydroxy group substituted by a heterocyclic ring containing N atom(s) (each of which is optionally substituted), R2 is a lower alkylamino group which is optionally substituted by an aryl group, a lower alkoxy group which is optionally substituted by an aryl group, a lower alkoxy group substituted by an aromatic heterocyclic ring containing N atom(s), R3 is an aryl group, a heterocyclic ring containing N atom(s), a lower alkyl group, a lower alkoxy group, a cyclo lower alkoxy group, a hydroxy group substituted by a heterocyclic ring containing N atom(s), or an amino group (each of which is optionally substituted), and R3 and a substituent in Y may be combined to form a lactone ring. The compound of the present invention has excellent selective PDE V inhibitory activity and therefore, is useful as a therapeutic or prophylactic drug for treating various diseases due to functional disorders on cGMP-signaling.
